Detalhe da pesquisa
1.
Evaluation of the Geographical Accessibility of Genome-Matched Clinical Trials on a National Experience.
Oncologist
; 29(2): 159-165, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37669224
2.
Deleterious alterations in homologous recombination repair genes and efficacy of platinum-based chemotherapy in biliary tract cancers.
Oncologist
; 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38823036
3.
Cancers of Unknown Primary Origin: Real-World Clinical Outcomes and Genomic Analysis at the European Institute of Oncology.
Oncologist
; 29(6): 504-510, 2024 Jun 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38520742
4.
Clinical actionability of BRCA2 alterations in uterine leiomyosarcoma: a molecular tumor board case report and a cBioPortal comprehensive analysis.
Oncologist
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38716772
5.
Baseline Tumor Size as Prognostic Index in Patients With Advanced Solid Tumors Receiving Experimental Targeted Agents.
Oncologist
; 29(1): 75-83, 2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37548439
6.
Immune-Related Adverse Event Likelihood Score Identifies "Pure" IRAEs Strongly Associated With Outcome in a Phase I-II Trial Population.
Oncologist
; 29(2): e266-e274, 2024 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37715957
7.
Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability.
Oncologist
; 28(11): 944-960, 2023 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665782
8.
Next-Generation Sequencing for Advanced Breast Cancer: What the Way to Go?
Cancer Treat Res
; 188: 343-351, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175352
9.
Fast Mimicking Diets and Other Innovative Nutritional Interventions to Treat Patients with Breast Cancer.
Cancer Treat Res
; 188: 199-218, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38175347
10.
Refining risk stratification in HR-positive/HER2-negative early breast cancer: how to select patients for treatment escalation?
Breast Cancer Res Treat
; 192(3): 465-484, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35124720
11.
The return of RET GateKeeper mutations? an in-silico exploratory analysis of potential resistance mechanisms to novel RET macrocyclic inhibitor TPX-0046.
Invest New Drugs
; 40(5): 1133-1136, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612671
12.
Systemic Treatment of Ductal Carcinoma In Situ of the Breast.
Chirurgia (Bucur)
; 116(5 Suppl): S97-S104, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34967317
13.
Adjuvant treatment of early male breast cancer.
Curr Opin Oncol
; 32(6): 594-602, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32852309
14.
Beyond PD(L)-1 Blockade in Microsatellite-Instable Cancers: Current Landscape of Immune Co-Inhibitory Receptor Targeting.
Cancers (Basel)
; 16(2)2024 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254772
15.
A demand-offer critical analysis of current drug development. Phase I drugs versus TCGA sequencing data.
Eur J Cancer
; 190: 112958, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37451181
16.
Variant allele frequency: a decision-making tool in precision oncology?
Trends Cancer
; 9(12): 1058-1068, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704501
17.
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?
Curr Oncol
; 30(5): 5072-5092, 2023 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37232842
18.
Molecular tumour board at European Institute of Oncology: Report of the first three year activity of an Italian precision oncology experience.
Eur J Cancer
; 183: 79-89, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36801623
19.
Targeting Cellular Components of the Tumor Microenvironment in Solid Malignancies.
Cancers (Basel)
; 14(17)2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077813
20.
PIK3CAMutations in Breast Cancer Subtypes Other Than HR-Positive/HER2-Negative.
J Pers Med
; 12(11)2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36579519